These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19819359)

  • 1. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma.
    Clifton J; Huang F; Gaso-Sokac D; Brilliant K; Hixson D; Josic D
    J Proteomics; 2010 Jan; 73(3):678-88. PubMed ID: 19819359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics as a tool for optimization of human plasma protein separation.
    Kovac S; Yang X; Huang F; Hixson D; Josic D
    J Chromatogr A; 2008 Jun; 1194(1):38-47. PubMed ID: 18486944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T; Michalski C; Goudemand M; Huart JJ
    Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of highly purified clotting factor IX by a combination of different chromatographic methods.
    Hoffer L; Schwinn H; Josić D
    J Chromatogr A; 1999 Jun; 844(1-2):119-28. PubMed ID: 10399328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis for process development and control of therapeutic protein separation from human plasma.
    Yang X; Clifton J; Huang F; Kovac S; Hixson DC; Josic D
    Electrophoresis; 2009 Apr; 30(7):1185-93. PubMed ID: 19291737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports.
    Ribeiro DA; Passos DF; Ferraz HC; Castilho LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():111-8. PubMed ID: 24076525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of commercial anion-exchange resins as solid support for peptide synthesis and affinity chromatography.
    Nakaie CR; Ianzer DA; Malavolta L; Cilli EM; Rodrigues MM
    Anal Biochem; 2003 Jul; 318(1):39-46. PubMed ID: 12782029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
    Feldman PA; Bradbury PI; Williams JD; Sims GE; McPhee JW; Pinnell MA; Harris L; Crombie GI; Evans DR
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):939-48. PubMed ID: 7893930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
    Ahmad SS; Rawala-Sheikh R; Thompson AR; Walsh PN
    Thromb Res; 1989 Jul; 55(1):121-33. PubMed ID: 2781515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of semi-industrial monolithic columns for downstream processing of clotting factor IX.
    Branović K; Buchacher A; Barut M; Strancar A; Josic D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):175-82. PubMed ID: 12767330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semi-continuous method for purification of factor IX complex from human plasma.
    Tharakan JP; Gee DM; Clark DB
    Vox Sang; 1989; 57(4):233-9. PubMed ID: 2617960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CNBr, FMP and hydrazide resins for immunoaffinity purification of factor IX.
    Highsmith F; Regan T; Clark D; Drohan W; Tharakan J
    Biotechniques; 1992 Mar; 12(3):418-23. PubMed ID: 1571154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an immunoaffinity process for factor IX purification.
    Tharakan J; Strickland D; Burgess W; Drohan WN; Clark DB
    Vox Sang; 1990; 58(1):21-9. PubMed ID: 2316207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of human vitamin K-dependent coagulation proteins using hydrophobic interaction chromatography.
    Husi H; Walkinshaw MD
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):77-88. PubMed ID: 10676986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
    Michalski C; Bal F; Burnouf T; Goudemand M
    Vox Sang; 1988; 55(4):202-10. PubMed ID: 3265237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
    Liebman HA; Limentani SA; Furie BC; Furie B
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3879-83. PubMed ID: 2408269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation of factor IX concentrate from cryosupernatant of donor's plasma].
    Fetisova LV; Viazova EP; Khametova RN; Shuvalova AL; Azhigirova MA; Lazarev VA; Zeĭnalov AM
    Gematol Transfuziol; 1991 Jun; 36(6):34-6. PubMed ID: 1769497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for systematic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin, factor X, factor IX, protein S, protein C, and protein Z.
    Hashimoto N; Morita T; Iwanaga S
    J Biochem; 1985 May; 97(5):1347-55. PubMed ID: 3161875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.